Comparison of pharmacokinetics of tilmicosin in healthy pigs and pigs experimentally infected with Actinobacillus pleuropneumoniae

References

• Abubasha EA, Idkaidek NM, Alshunnaq AF. Pharmacokinetics of tilmicosin (Provitil powder and Pulmotil liquid AC) oral formulations in chickens. Veterinary Research Communications 31, 477–85, 2007 doi: 10.1007/s11259-006-3543-6
   PubMed Web of Science ®Google Scholar
• Baggot JD, Mckellar QA. The absorption, distribution and elimination of anthelmintic drugs: the role of pharmacokinetics. Journal of Veterinary Pharmacology and Therapeutics 17, 409–19, 2010 doi: 10.1111/j.1365-2885.1994.tb00271.x
   Web of Science ®Google Scholar
• Christodoulopoulos G, Warnick LD, Papaioannou N, Fthenakis GC. Tilmicosin administration to young lambs with respiratory infection: safety and efficacy considerations. Journal of Veterinary Pharmacology and Therapeutics 25, 393–7, 2010 doi: 10.1046/j.1365-2885.2002.00433.x
   Web of Science ®Google Scholar
• El Garch F, De Jong A, Simjee S, Moyaert H, Klein U, Ludwig C, Marion H, Haag-Diergarten S, Richard-Mazet A, Thomas V. Monitoring of antimicrobial susceptibility of respiratory tract pathogens isolated from diseased cattle and pigs across Europe, 2009-2012: VetPath results. Veterinary Microbioogyl 194, 11–22, 2016 doi: 10.1016/j.vetmic.2016.04.009
   PubMed Web of Science ®Google Scholar
• Fittipaldi N, Klopfenstein C, Gottschalk M, Broes A, Paradis MA, Dick CP. Assessment of the efficacy of tilmicosin phosphate to eliminate Actinobacillus pleuropneumoniae from carrier pigs. Canadian Journal of Veterinary Research 69, 146–50, 2005
   PubMed Web of Science ®Google Scholar
• Gajda A, Bladek T, Jablonski A, Posyniak A. The influence of Actinobacillus pleuropneumoniae infection on tulathromycin pharmacokinetics and lung tissue disposition in pigs. Journal of Veterinary Pharmacology and Therapeutics 39, 176–82, 2016 doi: 10.1111/jvp.12259
   PubMed Web of Science ®Google Scholar
• Gibaldi M, Perrier D. Noncompartmental analysis based on statistical moment theory. Applied Cognitive Psychology 1, 217–9, 1982
   Google Scholar
• Gottschalk M. The challenge of detecting herds sub-clinically infected with Actinobacillus pleuropneumoniae. Veterinary Journal 206, 30–8, 2015 doi: 10.1016/j.tvjl.2015.06.016
   PubMed Web of Science ®Google Scholar
• Hoar BR, Jelinski MD, Ribble CS, Janzen ED, Johnson JC. A comparison of the clinical field efficacy and safety of florfenicol and tilmicosin for the treatment of undifferentiated bovine respiratory disease of cattle in western Canada. Canadian Veterinary Journal-Revue Veterinaire Canadienne 39, 161–6, 1998
   PubMed Web of Science ®Google Scholar
• Hoflack G, Maes D, Mateusen B, Verdonck M, De Kruif A. Efficacy of tilmicosin phosphate (Pulmotil premix) in feed for the treatment of a clinical outbreak of Actinobacillus pleuropneumoniae infection in growing-finishing pigs. Zoonoses and Public Health 48, 655–64, 2010
   Google Scholar
• Klinkenberg D, Tobias TJ, Bouma A, van Leengoed LA, Stegeman JA. Simulation study of the mechanisms underlying outbreaks of clinical disease caused by Actinobacillus pleuropneumoniae in finishing pigs. Veterinary Journal 202, 99–105, 2014 doi: 10.1016/j.tvjl.2014.06.015
   PubMed Web of Science ®Google Scholar
• Kucerova Z, Hradecka H, Nechvatalova K, Nedbalcova K. Antimicrobial susceptibility of Actinobacillus pleuropneumoniae isolates from clinical outbreaks of porcine respiratory diseases. Veterinary Microbiology 150, 203–6, 2011 doi: 10.1016/j.vetmic.2011.01.016
   PubMed Web of Science ®Google Scholar
• Ladefoged O. Pharmacokinetics of antipyrine and trimethoprim in pigs with endotoxin-induced fever. Journal of Veterinary Pharmacology and Therapeutics 2, 209–14, 2010 doi: 10.1111/j.1365-2885.1979.tb00377.x
   Google Scholar
• Lombardi KR, Portillo T, Hassfurther R, Hunter RP. Pharmacokinetics of tilmicosin in beef cattle following intravenous and subcutaneous administration. Journal of Veterinary Pharmacology and Therapeutics 34, 583–7, 2011 doi: 10.1111/j.1365-2885.2011.01268.x
   PubMed Web of Science ®Google Scholar
• Marois C, Gottschalk M, Morvan H, Fablet C, Madec F, Kobisch M. Experimental infection of SPF pigs with Actinobacillus pleuropneumoniae serotype 9 alone or in association with Mycoplasma hyopneumoniae. Veterinary Microbiology 135, 283–91, 2010 doi: 10.1016/j.vetmic.2008.09.061
   Web of Science ®Google Scholar
• Mateusen B, Maes D, Hoflack G, Verdonck M, De Kruif A. A comparative study of the preventive use of tilmicosin phosphate (Pulmotil premix) and Mycoplasma hyopneumoniae vaccination in a pig herd with chronic respiratory disease. Zoonoses and Public Health 48, 733–41, 2010
   Google Scholar
• Modric S, Webb AI, Derendorf H. Pharmacokinetics and pharmacodynamics of tilmicosin in sheep and cattle. Journal of Veterinary Pharmacology and Therapeutics 21, 444–52, 1998 doi: 10.1046/j.1365-2885.1998.00177.x
   PubMed Web of Science ®Google Scholar
• Modric S, Webb AI, Davidson M. Effect of respiratory tract disease on pharmacokinetics of tilmicosin in rats. Laboratory Animal Science 49, 248–53, 1999
   PubMedGoogle Scholar
• Moore GM, Basson RP, Tonkinson LV. Clinical field trials with tilmicosin phosphate in feed for the control of naturally acquired pneumonia caused by Actinobacillus pleuropneumoniae and Pasteurella multocida in swine. American Journal of Veterinary Research 57, 224–8, 1996
   PubMed Web of Science ®Google Scholar
• Naccari F, Giofrè F, Pellegrino M, Calò M, Licata P, Carli S. Effectiveness and kinetic behaviour of tilmicosin in the treatment of respiratory infections in sheep. Veterinary Record 148, 773–6, 2001 doi: 10.1136/vr.148.25.773
   PubMed Web of Science ®Google Scholar
• Paradis MA, Vessie GH, Merrill JK, Dick CP, Moore C, Charbonneau G, Gottschalk M, MacInnes JI, Higgins R, et al. Efficacy of tilmicosin in the control of experimentally induced Actinobacillus pleuropneumoniae infection in swine. Canadian Journal of Veterinary Research 68, 7–11, 2004
   PubMed Web of Science ®Google Scholar
• Pijpers A, Schoevers EJ, Van Gogh H, van Leengoed LA, Visser IJ, van Miert AS, Verheijden JH. The influence of disease on feed and water consumption and on pharmacokinetics of orally administered oxytetracycline in pigs. Journal of Animal Science 69, 2947–54, 1991 doi: 10.2527/1991.6972947x
   PubMed Web of Science ®Google Scholar
• Salmon SA, Watts JL, Case CA, Hoffman LJ, Wegener HC, Yancey RJ. Comparison of MICs of ceftiofur and other antimicrobial agents against bacterial pathogens of swine from the United States, Canada, and Denmark. Journal of Clinical Microbiology 33, 2435–44, 1995
   PubMed Web of Science ®Google Scholar
• Schaller A, Djordjevic SP, Eamens GJ, Forbes WA, Kuhn R, Kuhnert P, Gottschalk M, Nicolet J, Frey J. Identification and detection of Actinobacillus pleuropneumoniae by PCR based on the gene apx IVA. Veterinary Microbiology 79, 47–62, 2001 doi: 10.1016/S0378-1135(00)00345-X
   PubMed Web of Science ®Google Scholar
• Scorneaux B, Shryock TR. Intracellular accumulation, subcellular distribution, and efflux of tilmicosin in swine phagocytes. Journal of Veterinary Pharmacology and Therapeutics 21, 257–68, 1998 doi: 10.1046/j.1365-2885.1998.00133.x
   PubMed Web of Science ®Google Scholar
• Scorneaux B, Shryock TR. Intracellular accumulation, subcellular distribution, and efflux of tilmicosin in bovine mammary, blood, and lung cells. Journal of Dairy Science 82, 1202–12, 1999 doi: 10.3168/jds.S0022-0302(99)75343-9
   PubMed Web of Science ®Google Scholar
• Shen J, Li C, Jiang H, Zhang S, Guo P, Ding S, Li X. Pharmacokinetics of tilmicosin after oral administration in swine. American Journal of Veterinary Research 66, 1071–4, 2005 doi: 10.2460/ajvr.2005.66.1071
   PubMed Web of Science ®Google Scholar
• Stipkovits L, Miller D, Glavits R, Fodor L, Burch D. Treatment of pigs experimentally infected with Mycoplasma hyopneumoniae, Pasteurella multocida, and Actinobacillus pleuropneumoniae with various antibiotics. Canadian Journal of Veterinary Research 65, 213–22, 2001
   PubMed Web of Science ®Google Scholar
• Tobias TJ, Klinkenberg D, Bouma A, van den Broek J, Daemen AJ, Wagenaar JA, Stegeman JA. A cohort study on Actinobacillus pleuropneumoniae colonisation in suckling piglets. Preventive Veterinary Medicine 114, 223–30, 2014 doi: 10.1016/j.prevetmed.2014.02.008
   PubMed Web of Science ®Google Scholar
• Van Miert A. Influence of febrile disease on the pharmacokinetics of veterinary drugs. Annals of Veterinary Research 21 Suppl 1, 11S–28S, 1990
   PubMedGoogle Scholar
• Velthuis AG, De Jong MC, Kamp EM, Stockhofe N, Verheijden JH. Design and analysis of an Actinobacillus pleuropneumoniae transmission experiment. Preventive Veterinary Medicine 60, 53–68, 2003 doi: 10.1016/S0167-5877(03)00082-5
   PubMed Web of Science ®Google Scholar
• Xiong J, Zhu Q, Zhao Y, Yang S, Cao J, Qiu Y. Tilmicosin enteric granules and premix to pigs: antimicrobial susceptibility testing and comparative pharmacokinetics. Journal of Veterinary Pharmacology and Therapeutics 42, 336–45, 2019 doi: 10.1111/jvp.12753
   PubMed Web of Science ®Google Scholar
• Yuan ZH, Miao XQ, Yin YH. Pharmacokinetics of ampicillin and sulfadimidine in pigs infected experimentally with Streptococcus suum. Journal of Veterinary Pharmacology and Therapeutics 20, 318–22, 1997 doi: 10.1046/j.1365-2885.1997.00831.x
   PubMed Web of Science ®Google Scholar
• Zeng YG. Diagnosis and prevention of the infectious pleuropneumonia in pigs. Progress in Veterinary Medicine 6, 82–3, 2003
   Google Scholar
• Zhang P, Hao H, Li J, Ijaz A, Cheng G, Chen D, Tao Y, Huang L, Wang Y, Dai M. The epidemiologic and pharmacodynamic cutoff values of tilmicosin against Haemophilus parasuis. Frontiers in Microbiology 7, 385–9, 2016
   PubMed Web of Science ®Google Scholar
• Ziv G, Shbm-Tov M, Glickman A, Winkler M, Saran A. Tilmicosin antibacterial activity and pharmacokinetics in cows. Journal of Veterinary Pharmacology and Therapeutics 18, 340–5, 2010 doi: 10.1111/j.1365-2885.1995.tb00601.x
   Web of Science ®Google Scholar